Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in ...
High-throughput, high-content imaging-based assay developed to screen convalescent sera for neutralizing antibodies to SARS-CoV-2 variants Study highlights Tonix’s internal R&D capabilities in infectious disease that include a COVID-19 vaccine selected …